CUE
Price
$0.70
Change
+$0.01 (+1.45%)
Updated
Jul 3 closing price
Capitalization
52.38M
64 days until earnings call
HURA
Price
$2.48
Change
-$0.13 (-4.98%)
Updated
Jul 3 closing price
Capitalization
115.44M
Interact to see
Advertisement

CUE vs HURA

Header iconCUE vs HURA Comparison
Open Charts CUE vs HURABanner chart's image
Cue Biopharma
Price$0.70
Change+$0.01 (+1.45%)
Volume$66.63K
Capitalization52.38M
TuHURA Biosciences
Price$2.48
Change-$0.13 (-4.98%)
Volume$603.78K
Capitalization115.44M
CUE vs HURA Comparison Chart in %
Loading...
CUE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CUE vs. HURA commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CUE is a Hold and HURA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (CUE: $0.70 vs. HURA: $2.48)
Brand notoriety: CUE and HURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CUE: 31% vs. HURA: 232%
Market capitalization -- CUE: $52.38M vs. HURA: $115.44M
CUE [@Biotechnology] is valued at $52.38M. HURA’s [@Biotechnology] market capitalization is $115.44M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CUE’s FA Score shows that 0 FA rating(s) are green whileHURA’s FA Score has 0 green FA rating(s).

  • CUE’s FA Score: 0 green, 5 red.
  • HURA’s FA Score: 0 green, 5 red.
According to our system of comparison, HURA is a better buy in the long-term than CUE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CUE’s TA Score shows that 4 TA indicator(s) are bullish while HURA’s TA Score has 4 bullish TA indicator(s).

  • CUE’s TA Score: 4 bullish, 6 bearish.
  • HURA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, HURA is a better buy in the short-term than CUE.

Price Growth

CUE (@Biotechnology) experienced а -11.93% price change this week, while HURA (@Biotechnology) price change was +11.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.30%. For the same industry, the average monthly price growth was +17.40%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

CUE is expected to report earnings on Sep 08, 2025.

Industries' Descriptions

@Biotechnology (+6.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HURA($115M) has a higher market cap than CUE($52.4M). CUE YTD gains are higher at: -36.220 vs. HURA (-39.364). HURA has higher annual earnings (EBITDA): -19.52M vs. CUE (-37.52M). CUE has more cash in the bank: 13.1M vs. HURA (6.22M). HURA has less debt than CUE: HURA (165K) vs CUE (7.13M). CUE has higher revenues than HURA: CUE (7.99M) vs HURA (0).
CUEHURACUE / HURA
Capitalization52.4M115M46%
EBITDA-37.52M-19.52M192%
Gain YTD-36.220-39.36492%
P/E RatioN/AN/A-
Revenue7.99M0-
Total Cash13.1M6.22M211%
Total Debt7.13M165K4,318%
FUNDAMENTALS RATINGS
CUE vs HURA: Fundamental Ratings
CUE
HURA
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
67
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6335
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CUE's Valuation (59) in the Biotechnology industry is in the same range as HURA (67) in the null industry. This means that CUE’s stock grew similarly to HURA’s over the last 12 months.

CUE's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as HURA (100) in the null industry. This means that CUE’s stock grew similarly to HURA’s over the last 12 months.

CUE's SMR Rating (100) in the Biotechnology industry is in the same range as HURA (100) in the null industry. This means that CUE’s stock grew similarly to HURA’s over the last 12 months.

HURA's Price Growth Rating (35) in the null industry is in the same range as CUE (63) in the Biotechnology industry. This means that HURA’s stock grew similarly to CUE’s over the last 12 months.

HURA's P/E Growth Rating (100) in the null industry is in the same range as CUE (100) in the Biotechnology industry. This means that HURA’s stock grew similarly to CUE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CUEHURA
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
88%
Momentum
ODDS (%)
Bullish Trend 4 days ago
75%
Bearish Trend 4 days ago
89%
MACD
ODDS (%)
Bullish Trend 4 days ago
73%
Bullish Trend 4 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
78%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 5 days ago
85%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 24 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CUE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DNTUY21.730.08
+0.37%
Dentsu Group Inc.
SLDX0.05N/A
N/A
STELLA DIAGNOSTICS INC.
NMREF0.05N/A
N/A
Namibia Critical Metals Inc.
NORSF0.17N/A
N/A
NORSK TITANIUM AS
AFXXF18.33N/A
N/A
AFRY AB

CUE and

Correlation & Price change

A.I.dvisor indicates that over the last year, CUE has been loosely correlated with SGMT. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if CUE jumps, then SGMT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CUE
1D Price
Change %
CUE100%
+0.46%
SGMT - CUE
34%
Loosely correlated
+1.73%
OCS - CUE
33%
Loosely correlated
-0.81%
HURA - CUE
31%
Poorly correlated
-4.98%
INAB - CUE
30%
Poorly correlated
+0.93%
RIGL - CUE
29%
Poorly correlated
+1.50%
More

HURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, HURA has been closely correlated with BIORQ. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if HURA jumps, then BIORQ could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HURA
1D Price
Change %
HURA100%
-4.98%
BIORQ - HURA
73%
Closely correlated
-6.25%
GNPX - HURA
60%
Loosely correlated
-3.59%
SNSE - HURA
48%
Loosely correlated
-2.54%
BIVI - HURA
47%
Loosely correlated
-1.07%
INAB - HURA
36%
Loosely correlated
+0.93%
More